| Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages JS Wang, D Shum-Tim, J Galipeau, E Chedrawy, N Eliopoulos, RCJ Chiu The Journal of thoracic and cardiovascular surgery 120 (5), 999-1006, 2000 | 951 | 2000 |
| Allogeneic marrow stromal cells are immune rejected by MHC class I–and class II–mismatched recipient mice N Eliopoulos, J Stagg, L Lejeune, S Pommey, J Galipeau Blood 106 (13), 4057-4065, 2005 | 670 | 2005 |
| Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation B Annabi, YT Lee, S Turcotte, E Naud, RR Desrosiers, M Champagne, ... Stem cells 21 (3), 337-347, 2003 | 424 | 2003 |
| Radiation-induced oral mucositis OM Maria, N Eliopoulos, T Muanza Frontiers in oncology 7, 89, 2017 | 422 | 2017 |
| Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell J Stagg, S Pommey, N Eliopoulos, J Galipeau Blood 107 (6), 2570-2577, 2006 | 404 | 2006 |
| Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo A Al-Khaldi, N Eliopoulos, D Martineau, L Lejeune, K Lachapelle, ... Gene therapy 10 (8), 621-629, 2003 | 331 | 2003 |
| Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis … J Cuerquis, R Romieu-Mourez, M François, JP Routy, YK Young, J Zhao, ... Cytotherapy 16 (2), 191-202, 2014 | 139 | 2014 |
| Drug resistance to 5-aza-2′-deoxycytidine, 2′, 2′-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA … N Eliopoulos, D Cournoyer, RL Momparler Cancer chemotherapy and pharmacology 42, 373-378, 1998 | 138 | 1998 |
| Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors B Annabi, E Naud, YT Lee, N Eliopoulos, J Galipeau Journal of cellular biochemistry 91 (6), 1146-1158, 2004 | 121 | 2004 |
| Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection N Eliopoulos, J Zhao, M Bouchentouf, K Forner, E Birman, S Yuan, ... American Journal of Physiology-Renal Physiology 299 (6), F1288-F1298, 2010 | 109 | 2010 |
| Pharmacological approach for optimization of the dose schedule of 5-Aza-2’-deoxycytidine (Decitabine) for the therapy of leukemia RL Momparler, S Cote, N Eliopoulos Leukemia 11 (2), 175-180, 1997 | 108 | 1997 |
| Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence J Corcos, O Loutochin, L Campeau, N Eliopoulos, M Bouchentouf, B Blok, ... Neurourology and urodynamics 30 (3), 447-455, 2011 | 102 | 2011 |
| Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy N Eliopoulos, M Francois, MN Boivin, D Martineau, J Galipeau Cancer research 68 (12), 4810-4818, 2008 | 100 | 2008 |
| Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro DM Iglesias, R El-Kares, A Taranta, F Bellomo, F Emma, M Besouw, ... Public Library of Science 7 (8), e42840, 2012 | 89 | 2012 |
| Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure N Eliopoulos, RF Gagnon, M Francois, J Galipeau Journal of the American Society of Nephrology 17 (6), 1576-1584, 2006 | 84 | 2006 |
| Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells B Annabi, S Thibeault, YT Lee, N Bousquet-Gagnon, N Eliopoulos, ... Experimental Hematology 31 (7), 640-649, 2003 | 83 | 2003 |
| CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization I Copland, K Sharma, L Lejeune, N Eliopoulos, D Stewart, P Liu, ... Experimental Hematology 36 (1), 93-103, 2008 | 74 | 2008 |
| Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. RL Momparler, N Eliopoulos, V Bovenzi, S Letourneau, M Greenbaum, ... Cancer Gene Therapy 3 (5), 331-338, 1996 | 74 | 1996 |
| Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform BF Benabdallah, E Allard, S Yao, G Friedman, PD Gregory, N Eliopoulos, ... Cytotherapy 12 (3), 394-399, 2010 | 71 | 2010 |
| A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated … N Eliopoulos, A Al-Khaldi, M Crosato, K Lachapelle, J Galipeau Gene Therapy 10 (6), 478-489, 2003 | 65 | 2003 |
